Download the Protocol

DSIP

DSIP is a small natural compound that helps the body relax and enter deep, restful sleep. It has calming effects on the brain and may support recovery by helping balance stress and sleep hormones. Research focuses on its potential to improve sleep quality and reduce stress levels.

Description

• DSIP is a naturally occurring neuropeptide first isolated from the hypothalamus, associated with regulation of sleep and stress response.
• It modulates the central nervous system and influences endocrine and sleep–wake cycles in animal research.
• Used experimentally to study deep sleep induction, hormonal balance, and neuroprotection.

How It Works

• Acts on the hypothalamic–pituitary–adrenal (HPA) axis to promote relaxation and deep sleep states.
• May normalize cortisol rhythms and stimulate GH release during sleep cycles.
• Interacts with GABAergic and serotonergic systems to reduce neuronal excitability.

Documented Effects

• Facilitates deep (slow-wave) sleep and enhances sleep quality in animal models.
• Reduces stress markers and normalizes ACTH/cortisol levels.
• Shows neuroprotective and antioxidant activity under experimental conditions.

Theoretical Effects

• Potential applications in sleep research, recovery enhancement, and neuroendocrine studies.
• Long-term effects in humans remain inconclusive.

Pharmacokinetics

• Half-life: approximately 2–4 hours after subcutaneous administration.
• Time to peak concentration: 30–60 minutes post-injection.
• Steady-state: not reached; short-acting peptide cleared within several hours.

Duration of Effects

• Onset of relaxation within 30–60 minutes after injection.
• Sleep-promoting effects last 4–6 hours, aligning with normal sleep cycles.
• No residual sedation after discontinuation; effects wear off within one day.

Reconstitution

• Use only bacteriostatic water to reconstitute the lyophilized powder.
• Example vial: 5 mg of DSIP
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 5 mg/mL → 500 mcg per 10 units
  • 2 mL water → 2.5 mg/mL → 250 mcg per 10 units
• Swirl gently to dissolve; do not shake.
• Refrigerate reconstituted solution (2–8 °C). Use within ~14 days for best stability.

Injectable Dosage Overview (Research Use)

Typical Starting Dose

• 100 mcg subcutaneous (SC) once daily before sleep.
• Conservative start: 50–100 mcg to evaluate sensitivity.

Common Research Range

• 100–300 mcg SC nightly depending on desired effect and study duration.
• Can be paired with GHRP or GHRH analogs to study sleep–GH interaction.

Maximum Research Range

• Up to 500 mcg SC daily reported; higher doses show limited incremental benefit.

Standard Cycle Length

• 4–8 weeks continuous use in sleep or recovery studies, followed by evaluation phase.

Clinical Notes

• Administer subcutaneously 30–60 minutes before intended sleep time.
• No tapering required; short-acting with minimal residual effects.
• Stable for about 14 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.
• Should not be combined with other sedative or hypnotic research compounds.

Safety Notes (First-Time Use)

• Possible mild drowsiness, vivid dreams, or transient fatigue at start.
• Use sterile technique; ensure verified peptide source and purity.
• Research use only; not for therapeutic application.